Get the Stockscreener App
17.83
3.83%
-0.71
After Hours:
17.95
0.12
+0.67%
Overview
News
Price History
Option Chain
Financials
Why TEVA Down?
Discussions
Forecast
Stock Split
Dividend History
Teva Pharmaceutical Industries Ltd Adr stock is traded at $17.83, with a volume of 32.81M.
It is down -3.83% in the last 24 hours and down -20.12% over the past month.
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
See More
Previous Close:
$18.54
Open:
$18.56
24h Volume:
32.81M
Relative Volume:
3.41
Market Cap:
$20.07B
Revenue:
$16.77B
Net Income/Loss:
$-959.00M
P/E Ratio:
-20.98
EPS:
-0.85
Net Cash Flow:
$1.37B
1W Performance:
-18.17%
1M Performance:
-20.12%
6M Performance:
+8.65%
1Y Performance:
+52.00%
1-Day Range:
$17.51
$18.58
1-Week Range:
$17.51
$22.40
52-Week Range:
$11.62
$22.80
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile
Name
Teva Pharmaceutical Industries Ltd Adr
Sector
Phone
972 (3) 914-8213
Address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
Compare TEVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.83 | 20.07B | 16.77B | -959.00M | 1.37B | -0.85 |
|
ZTS
Zoetis Inc
|
172.80 | 78.39B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.69 | 43.65B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
HLN
Haleon Plc Adr
|
9.57 | 43.41B | 14.26B | 1.55B | 0 | 0.3383 |
|
NBIX
Neurocrine Biosciences Inc
|
153.29 | 15.53B | 2.24B | 385.90M | 440.10M | 3.73 |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-24 | Upgrade | Argus | Hold → Buy |
| Mar-08-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-12-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-23-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Upgrade | Piper Sandler | Underweight → Neutral |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Nov-27-23 | Upgrade | UBS | Neutral → Buy |
| Jul-06-23 | Upgrade | UBS | Sell → Neutral |
| May-25-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-19-23 | Downgrade | Jefferies | Buy → Hold |
| Nov-14-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-04-22 | Downgrade | UBS | Neutral → Sell |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Aug-05-22 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-14-22 | Resumed | UBS | Neutral |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-04-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Apr-05-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-25-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-27-22 | Downgrade | Argus | Buy → Hold |
| Oct-28-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-04-21 | Downgrade | UBS | Buy → Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-25-20 | Initiated | Oppenheimer | Perform |
| Aug-06-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-27-20 | Resumed | Goldman | Neutral |
| Jun-01-20 | Upgrade | SunTrust | Hold → Buy |
| Apr-24-20 | Resumed | Citigroup | Neutral |
| Apr-06-20 | Upgrade | UBS | Neutral → Buy |
| Feb-24-20 | Downgrade | Edward Jones | Hold → Sell |
| Nov-12-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Oct-17-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-07-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-19-19 | Initiated | Wolfe Research | Peer Perform |
| Jul-15-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-10-19 | Resumed | Credit Suisse | Neutral |
| Jul-05-19 | Upgrade | Argus | Hold → Buy |
| Jun-11-19 | Initiated | Barclays | Underweight |
| Jun-03-19 | Upgrade | Oppenheimer | Perform → Outperform |
| May-30-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| May-28-19 | Downgrade | UBS | Buy → Neutral |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-07-19 | Resumed | UBS | Buy |
View All
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Latest News
Why Teva Pharmaceutical Stock Is Sinking Today - The Motley Fool
Teva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO. - Investor's Business Daily
Are You Looking for a Top Momentum Pick? Why Sea Limited Sponsored ADR (SE) is a Great Choice - Yahoo Finance
Does Starbucks Corp (NASDAQ: SBUX) Still Need To Convince Analysts? - Stocks Register
Wells Fargo & Co (NYSE: WFC) Jumps 0.80%, Turning Investors Away - Stocks Register
Does Petroleo Brasileiro S.A. Petrobras ADR (NYSE: PBR) Still Look Hot This Week? - Stocks Register
MINISO Group Holding Limited Unsponsored ADR (MNSO) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Exicure Inc (XCUR) requires closer examination - US Post News
Citizens Financial Group Inc (NYSE: CFG) Stock Forecast: Bearish Sentiment Points To -1.52% Downside In 2025 - Stocks Register
Is It Worth Investing in PDD Holdings Inc. Sponsored ADR (PDD) Based on Wall Street's Bullish Views? - Yahoo Finance
Brainsway Ltd. Sponsored ADR (BWAY) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Hewlett Packard Enterprise Co (NYSE: HPE) Stock Forecast: Could Pass $29 In A Year - Stocks Register
Citigroup Inc (NYSE: C) Up 37.25% This Year: What Is Going To Happen Next - Stocks Register
Where Do Analysts Think The Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Is Going - Stocks Register
Is Capricorn Energy PLC Unsponsored ADR (CRNCY) Stock Outpacing Its Oils-Energy Peers This Year? - Yahoo Finance
New Strong Buy Stocks for January 2nd - Yahoo Finance
Are Medical Stocks Lagging Brainsway (BWAY) This Year? - Yahoo Finance
Fortuna Mining Corp Still Hasn’t Convinced Analysts? - Stocks Register
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) 0.56% Incline Turns Investors Away - Stocks Register
Is Now The Time To Buy Abbvie Inc (NYSE: ABBV) Stock? - Stocks Register
PayPal Holdings Inc (NASDAQ: PYPL) Could Pass $95 In One Year Stock Forecast - Stocks Register
How Do Things Look For Boeing Co (NYSE: BA) In The Short-Term? - Stocks Register
What Did We Note About Insider Trading At Energy Transfer LP (NYSE: ET)? - Stocks Register
SelectQuote Inc Still Hasn’t Convinced Analysts? - Stocks Register
Barclays plc ADR (NYSE: BCS) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
What Did We Note About Insider Trading At Altice USA Inc (NYSE: ATUS)? - Stocks Register
Walmart Inc (NYSE: WMT) -2.05% Decline Turns Investors Away - Stocks Register
What Did We Note About Insider Trading At Microsoft Corporation (NASDAQ: MSFT)? - Stocks Register
Where Do Analysts Think The Itau Unibanco Holding S.A. ADR (NYSE: ITUB) Is Going - Stocks Register
Hewlett Packard Enterprise Co (NYSE: HPE) Up 28.35% This Year: What Is Going To Happen Next - Stocks Register
Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily
Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug - Investor's Business Daily
Sandoz Group AG Sponsored ADR (SDZNY) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet - Yahoo Finance
Is Kingsoft Cloud (KC) Outperforming Other Computer and Technology Stocks This Year? - Yahoo Finance
Opera Gains 27% in 3 Months: Should You Buy, Sell or Hold the Stock? - Yahoo Finance
Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - Yahoo Finance
Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Hello Group Inc. Sponsored ADR (MOMO) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
Are Medical Stocks Lagging Adagene (ADAG) This Year? - Yahoo Finance
Teva Pharmaceutical ADR Gets Relative Strength Rating Upgrade - Investor's Business Daily
Saudi Arabia Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research
Why Novo Nordisk A/S (NVO) Is the Best ADR Stock to Invest in? - Yahoo Finance
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
New Strong Buy Stocks for November 26th - Yahoo Finance
Why MINISO Group Holding Limited Unsponsored ADR (MNSO) Outpaced the Stock Market Today - Yahoo Finance
Petrobras to Distribute R$ 20 Billion in Dividends - Yahoo Finance
10 Stocks With the Largest Fair Value Estimate Increases After Q3 Earnings - Morningstar
BioLineRx, Ayrmid enter license agreement for motixafortide through Gamida Cell - Yahoo Finance
Is Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Outperforming Other Consumer Discretionary Stocks This Year? - Yahoo Finance
Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):